Skip to main content
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · TARS ISIN · US87650L1035 US Manufacturing
Filings indexed 576 across all filing types
Latest filing 2026-05-06 Report Publication Anno…
Country US United States of America
Listing US TARS

About Tarsus Pharmaceuticals, Inc.

https://www.tarsusrx.com/

Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.

Recent filings

Filing Released Lang Actions
8-K - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K “Current Report” pursuant to the Exchange Act. It runs ~3,783 characters and simply states that a press release setting forth quarterly results is attached as Exhibit 99.1. It does not contain the actual financial statements or substantive financial data itself but announces the publication of that press release. Under the “menu vs. meal” rule, short filings that note an attached report should be classified as a Report Publication Announcement (RPA), not as the report itself.
2026-05-06 English
144 - Tarsus Pharmaceuticals, Inc. (0001819790) (Subject)
Regulatory Filings
2026-03-20 English
4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer)
Director's Dealing
2026-03-20 English
4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer)
Director's Dealing
2026-03-20 English
4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer)
Director's Dealing
2026-03-20 English
4 - Tarsus Pharmaceuticals, Inc. (0001819790) (Issuer)
Director's Dealing
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.